New Results
Elevated alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
View ORCID ProfileScott C. Ritchie, Johannes Kettunen, Marta Brozynska, Artika P. Nath, Aki S. Havulinna, Satu Männisto, Markus Perola, Veikko Salomaa, Mika Ala-Korpela, Gad Abraham, Peter Würtz, Michael Inouye
doi: https://doi.org/10.1101/309138
Scott C. Ritchie
1Systems Genomics Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
2Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom
3Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia
4School of BioSciences, The University of Melbourne, Parkville, VIC 3010, Australia
Johannes Kettunen
5Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu 90014, Finland
6National Institute for Health and Welfare, Helsinki 00271, Finland
7NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland
Marta Brozynska
1Systems Genomics Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
2Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom
3Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia
4School of BioSciences, The University of Melbourne, Parkville, VIC 3010, Australia
Artika P. Nath
1Systems Genomics Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
8Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia
Aki S. Havulinna
6National Institute for Health and Welfare, Helsinki 00271, Finland
9Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland
Satu Männisto
6National Institute for Health and Welfare, Helsinki 00271, Finland
Markus Perola
6National Institute for Health and Welfare, Helsinki 00271, Finland
9Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland
Veikko Salomaa
6National Institute for Health and Welfare, Helsinki 00271, Finland
Mika Ala-Korpela
5Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu 90014, Finland
7NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland
10Population Health Science, Bristol Medical School, University of Bristol, Bristol BS8 1TH, UK
11Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK
12Systems Epidemiology Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
13Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia
Gad Abraham
1Systems Genomics Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
2Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom
3Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia
4School of BioSciences, The University of Melbourne, Parkville, VIC 3010, Australia
Peter Würtz
14Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland
15Nightingale Health Ltd, Helsinki, Finland
Michael Inouye
1Systems Genomics Lab, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
2Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom
3Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia
4School of BioSciences, The University of Melbourne, Parkville, VIC 3010, Australia
Posted April 26, 2018.
Elevated alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
Scott C. Ritchie, Johannes Kettunen, Marta Brozynska, Artika P. Nath, Aki S. Havulinna, Satu Männisto, Markus Perola, Veikko Salomaa, Mika Ala-Korpela, Gad Abraham, Peter Würtz, Michael Inouye
bioRxiv 309138; doi: https://doi.org/10.1101/309138
Elevated alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
Scott C. Ritchie, Johannes Kettunen, Marta Brozynska, Artika P. Nath, Aki S. Havulinna, Satu Männisto, Markus Perola, Veikko Salomaa, Mika Ala-Korpela, Gad Abraham, Peter Würtz, Michael Inouye
bioRxiv 309138; doi: https://doi.org/10.1101/309138
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8754)
- Bioinformatics (29205)
- Biophysics (14975)
- Cancer Biology (12102)
- Cell Biology (17414)
- Clinical Trials (138)
- Developmental Biology (9423)
- Ecology (14185)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12246)
- Genomics (16805)
- Immunology (11870)
- Microbiology (28098)
- Molecular Biology (11598)
- Neuroscience (60979)
- Paleontology (452)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4960)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7341)
- Zoology (1651)